ADHD Medication Market, Global Outlook and Forecast 2022-2028

April 2022 | 61 pages | ID: ADD2822D8AC5EN
Market Monitor Global

Abstracts

Stimulants are the best and most common type of medication used to treat ADHD.

This report contains market size and forecasts of ADHD Medication in Global, including the following market information:

Global ADHD Medication Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global ADHD Medication market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Stimulant Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of ADHD Medication include Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Inc, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals and Noven Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ADHD Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global ADHD Medication Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global ADHD Medication Market Segment Percentages, by Type, 2021 (%)

• Stimulant
• Non-stimulant

Global ADHD Medication Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global ADHD Medication Market Segment Percentages, by Application, 2021 (%)

• Attention Deficit
• Hyperactivity/impulse Control Disorder
• Hybrid

Global ADHD Medication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global ADHD Medication Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies ADHD Medication revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies ADHD Medication revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Takeda
• Johnson & Johnson
• Novartis
• Eli Lilly
• Tris Pharma, Inc
• Neos Therapeutics
• Mallinckrodt
• Amneal Pharmaceuticals
• Noven Pharmaceuticals
• Purdue Parma
• Zhengda Fenghai

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 ADHD Medication Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global ADHD Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ADHD MEDICATION OVERALL MARKET SIZE

2.1 Global ADHD Medication Market Size: 2021 VS 2028
2.2 Global ADHD Medication Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top ADHD Medication Players in Global Market
3.2 Top Global ADHD Medication Companies Ranked by Revenue
3.3 Global ADHD Medication Revenue by Companies
3.4 Top 3 and Top 5 ADHD Medication Companies in Global Market, by Revenue in 2021
3.5 Global Companies ADHD Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 ADHD Medication Players in Global Market
  3.6.1 List of Global Tier 1 ADHD Medication Companies
  3.6.2 List of Global Tier 2 and Tier 3 ADHD Medication Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global ADHD Medication Market Size Markets, 2021 & 2028
  4.1.2 Stimulant
  4.1.3 Non-stimulant
4.2 By Type - Global ADHD Medication Revenue & Forecasts
  4.2.1 By Type - Global ADHD Medication Revenue, 2017-2022
  4.2.2 By Type - Global ADHD Medication Revenue, 2023-2028
  4.2.3 By Type - Global ADHD Medication Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global ADHD Medication Market Size, 2021 & 2028
  5.1.2 Attention Deficit
  5.1.3 Hyperactivity/impulse Control Disorder
  5.1.4 Hybrid
5.2 By Application - Global ADHD Medication Revenue & Forecasts
  5.2.1 By Application - Global ADHD Medication Revenue, 2017-2022
  5.2.2 By Application - Global ADHD Medication Revenue, 2023-2028
  5.2.3 By Application - Global ADHD Medication Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global ADHD Medication Market Size, 2021 & 2028
6.2 By Region - Global ADHD Medication Revenue & Forecasts
  6.2.1 By Region - Global ADHD Medication Revenue, 2017-2022
  6.2.2 By Region - Global ADHD Medication Revenue, 2023-2028
  6.2.3 By Region - Global ADHD Medication Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America ADHD Medication Revenue, 2017-2028
  6.3.2 US ADHD Medication Market Size, 2017-2028
  6.3.3 Canada ADHD Medication Market Size, 2017-2028
  6.3.4 Mexico ADHD Medication Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe ADHD Medication Revenue, 2017-2028
  6.4.2 Germany ADHD Medication Market Size, 2017-2028
  6.4.3 France ADHD Medication Market Size, 2017-2028
  6.4.4 U.K. ADHD Medication Market Size, 2017-2028
  6.4.5 Italy ADHD Medication Market Size, 2017-2028
  6.4.6 Russia ADHD Medication Market Size, 2017-2028
  6.4.7 Nordic Countries ADHD Medication Market Size, 2017-2028
  6.4.8 Benelux ADHD Medication Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia ADHD Medication Revenue, 2017-2028
  6.5.2 China ADHD Medication Market Size, 2017-2028
  6.5.3 Japan ADHD Medication Market Size, 2017-2028
  6.5.4 South Korea ADHD Medication Market Size, 2017-2028
  6.5.5 Southeast Asia ADHD Medication Market Size, 2017-2028
  6.5.6 India ADHD Medication Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America ADHD Medication Revenue, 2017-2028
  6.6.2 Brazil ADHD Medication Market Size, 2017-2028
  6.6.3 Argentina ADHD Medication Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa ADHD Medication Revenue, 2017-2028
  6.7.2 Turkey ADHD Medication Market Size, 2017-2028
  6.7.3 Israel ADHD Medication Market Size, 2017-2028
  6.7.4 Saudi Arabia ADHD Medication Market Size, 2017-2028
  6.7.5 UAE ADHD Medication Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Takeda
  7.1.1 Takeda Corporate Summary
  7.1.2 Takeda Business Overview
  7.1.3 Takeda ADHD Medication Major Product Offerings
  7.1.4 Takeda ADHD Medication Revenue in Global Market (2017-2022)
  7.1.5 Takeda Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson ADHD Medication Major Product Offerings
  7.2.4 Johnson & Johnson ADHD Medication Revenue in Global Market (2017-2022)
  7.2.5 Johnson & Johnson Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis ADHD Medication Major Product Offerings
  7.3.4 Novartis ADHD Medication Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Eli Lilly
  7.4.1 Eli Lilly Corporate Summary
  7.4.2 Eli Lilly Business Overview
  7.4.3 Eli Lilly ADHD Medication Major Product Offerings
  7.4.4 Eli Lilly ADHD Medication Revenue in Global Market (2017-2022)
  7.4.5 Eli Lilly Key News
7.5 Tris Pharma, Inc
  7.5.1 Tris Pharma, Inc Corporate Summary
  7.5.2 Tris Pharma, Inc Business Overview
  7.5.3 Tris Pharma, Inc ADHD Medication Major Product Offerings
  7.5.4 Tris Pharma, Inc ADHD Medication Revenue in Global Market (2017-2022)
  7.5.5 Tris Pharma, Inc Key News
7.6 Neos Therapeutics
  7.6.1 Neos Therapeutics Corporate Summary
  7.6.2 Neos Therapeutics Business Overview
  7.6.3 Neos Therapeutics ADHD Medication Major Product Offerings
  7.6.4 Neos Therapeutics ADHD Medication Revenue in Global Market (2017-2022)
  7.6.5 Neos Therapeutics Key News
7.7 Mallinckrodt
  7.7.1 Mallinckrodt Corporate Summary
  7.7.2 Mallinckrodt Business Overview
  7.7.3 Mallinckrodt ADHD Medication Major Product Offerings
  7.7.4 Mallinckrodt ADHD Medication Revenue in Global Market (2017-2022)
  7.7.5 Mallinckrodt Key News
7.8 Amneal Pharmaceuticals
  7.8.1 Amneal Pharmaceuticals Corporate Summary
  7.8.2 Amneal Pharmaceuticals Business Overview
  7.8.3 Amneal Pharmaceuticals ADHD Medication Major Product Offerings
  7.8.4 Amneal Pharmaceuticals ADHD Medication Revenue in Global Market (2017-2022)
  7.8.5 Amneal Pharmaceuticals Key News
7.9 Noven Pharmaceuticals
  7.9.1 Noven Pharmaceuticals Corporate Summary
  7.9.2 Noven Pharmaceuticals Business Overview
  7.9.3 Noven Pharmaceuticals ADHD Medication Major Product Offerings
  7.9.4 Noven Pharmaceuticals ADHD Medication Revenue in Global Market (2017-2022)
  7.9.5 Noven Pharmaceuticals Key News
7.10 Purdue Parma
  7.10.1 Purdue Parma Corporate Summary
  7.10.2 Purdue Parma Business Overview
  7.10.3 Purdue Parma ADHD Medication Major Product Offerings
  7.10.4 Purdue Parma ADHD Medication Revenue in Global Market (2017-2022)
  7.10.5 Purdue Parma Key News
7.11 Zhengda Fenghai
  7.11.1 Zhengda Fenghai Corporate Summary
  7.11.2 Zhengda Fenghai Business Overview
  7.11.3 Zhengda Fenghai ADHD Medication Major Product Offerings
  7.11.4 Zhengda Fenghai ADHD Medication Revenue in Global Market (2017-2022)
  7.11.5 Zhengda Fenghai Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. ADHD Medication Market Opportunities & Trends in Global Market
Table 2. ADHD Medication Market Drivers in Global Market
Table 3. ADHD Medication Market Restraints in Global Market
Table 4. Key Players of ADHD Medication in Global Market
Table 5. Top ADHD Medication Players in Global Market, Ranking by Revenue (2021)
Table 6. Global ADHD Medication Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global ADHD Medication Revenue Share by Companies, 2017-2022
Table 8. Global Companies ADHD Medication Product Type
Table 9. List of Global Tier 1 ADHD Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 ADHD Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global ADHD Medication Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - ADHD Medication Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - ADHD Medication Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global ADHD Medication Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - ADHD Medication Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - ADHD Medication Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global ADHD Medication Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global ADHD Medication Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global ADHD Medication Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America ADHD Medication Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America ADHD Medication Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe ADHD Medication Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe ADHD Medication Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia ADHD Medication Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia ADHD Medication Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America ADHD Medication Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America ADHD Medication Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa ADHD Medication Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa ADHD Medication Revenue, (US$, Mn), 2023-2028
Table 30. Takeda Corporate Summary
Table 31. Takeda ADHD Medication Product Offerings
Table 32. Takeda ADHD Medication Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson ADHD Medication Product Offerings
Table 35. Johnson & Johnson ADHD Medication Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis ADHD Medication Product Offerings
Table 38. Novartis ADHD Medication Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lilly Corporate Summary
Table 40. Eli Lilly ADHD Medication Product Offerings
Table 41. Eli Lilly ADHD Medication Revenue (US$, Mn), (2017-2022)
Table 42. Tris Pharma, Inc Corporate Summary
Table 43. Tris Pharma, Inc ADHD Medication Product Offerings
Table 44. Tris Pharma, Inc ADHD Medication Revenue (US$, Mn), (2017-2022)
Table 45. Neos Therapeutics Corporate Summary
Table 46. Neos Therapeutics ADHD Medication Product Offerings
Table 47. Neos Therapeutics ADHD Medication Revenue (US$, Mn), (2017-2022)
Table 48. Mallinckrodt Corporate Summary
Table 49. Mallinckrodt ADHD Medication Product Offerings
Table 50. Mallinckrodt ADHD Medication Revenue (US$, Mn), (2017-2022)
Table 51. Amneal Pharmaceuticals Corporate Summary
Table 52. Amneal Pharmaceuticals ADHD Medication Product Offerings
Table 53. Amneal Pharmaceuticals ADHD Medication Revenue (US$, Mn), (2017-2022)
Table 54. Noven Pharmaceuticals Corporate Summary
Table 55. Noven Pharmaceuticals ADHD Medication Product Offerings
Table 56. Noven Pharmaceuticals ADHD Medication Revenue (US$, Mn), (2017-2022)
Table 57. Purdue Parma Corporate Summary
Table 58. Purdue Parma ADHD Medication Product Offerings
Table 59. Purdue Parma ADHD Medication Revenue (US$, Mn), (2017-2022)
Table 60. Zhengda Fenghai Corporate Summary
Table 61. Zhengda Fenghai ADHD Medication Product Offerings
Table 62. Zhengda Fenghai ADHD Medication Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. ADHD Medication Segment by Type in 2021
Figure 2. ADHD Medication Segment by Application in 2021
Figure 3. Global ADHD Medication Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global ADHD Medication Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global ADHD Medication Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by ADHD Medication Revenue in 2021
Figure 8. By Type - Global ADHD Medication Revenue Market Share, 2017-2028
Figure 9. By Application - Global ADHD Medication Revenue Market Share, 2017-2028
Figure 10. By Region - Global ADHD Medication Revenue Market Share, 2017-2028
Figure 11. By Country - North America ADHD Medication Revenue Market Share, 2017-2028
Figure 12. US ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 13. Canada ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe ADHD Medication Revenue Market Share, 2017-2028
Figure 16. Germany ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 17. France ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 19. Italy ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 20. Russia ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia ADHD Medication Revenue Market Share, 2017-2028
Figure 24. China ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 25. Japan ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 28. India ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America ADHD Medication Revenue Market Share, 2017-2028
Figure 30. Brazil ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa ADHD Medication Revenue Market Share, 2017-2028
Figure 33. Turkey ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 34. Israel ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 36. UAE ADHD Medication Revenue, (US$, Mn), 2017-2028
Figure 37. Takeda ADHD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson ADHD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis ADHD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lilly ADHD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Tris Pharma, Inc ADHD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Neos Therapeutics ADHD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Mallinckrodt ADHD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Amneal Pharmaceuticals ADHD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Noven Pharmaceuticals ADHD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Purdue Parma ADHD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Zhengda Fenghai ADHD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)